Source: Eur Respir J 2013; 42: 802-825



Rating:

Share or cite this content

Citations should be made in the following way:
Craig E. Wheelock, Victoria M. Goss, David Balgoma, Ben Nicholas, Joost Brandsma, Paul J. Skipp, Stuart Snowden, Dominic Burg, Arnaldo D'Amico, Ildiko Horvath, Amphun Chaiboonchoe, Hassan Ahmed, Stéphane Ballereau, Christos Rossios, Kian Fan Chung, Paolo Montuschi, Stephen J. Fowler, Ian M. Adcock, Anthony D. Postle, Sven-Erik Dahlén, Anthony Rowe, Peter J. Sterk, Charles Auffray, Ratko Djukanovi?, the U-BIOPRED Study Group. Application of ’omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013; 42: 802-825

Member's Comments

No comment yet.

Related content which might interest you: High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Application of 'omics to uncover novel disease pathways Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare Year: 2013 Biomarker discovery, development, and implementation in interstitial lung diseases Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 The genetics of asthma and the promise of genomics-guided drug discovery Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020 Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease Source: International Congress 2017 – Update on TB: latest news Year: 2017 The omics approach to defining endotypes and personalising treatment pathways in asthma Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 Radiomics in lung cancer: progress and challenges Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021 Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema Source: ERS Lung Science Conference 2016 Year: 2016 Interference RNA as a new tool and possible future therapy for inflammatory lung disease Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease” Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 LSC Abstract – Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 High-resolution quantitative proteomics applied to the discovery of biomarkers of innate immune response in tuberculosis. Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 How to build a lung: latest advances and emerging themes in lung bioengineering Source: Eur Respir J, 52 (1) 1601355; 10.1183/13993003.01355-2016 Year: 2018 The electronic nose: emerging biomarkers in lung cancer diagnostics Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019 Year: 2019 Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016